Group Leader: Marek Pruszyński, PhD, DSc

GROUP LEADER: Marek Pruszyński, PhD, DSc Marek Pruszyński, PhD, DSc

Dr Marek Pruszyński earned his Master’s degree in Chemistry from the Faculty of Biology and Chemistry at the University of Bialystok. In 2008, he completed his PhD in Chemistry at the Institute of Nuclear Chemistry and Technology (IChTJ) in Warsaw, where he later achieved his habilitation (DSc) in Chemistry in 2019. Since May 2021, Dr Pruszyński has been an Associate Professor at the National Centre for Nuclear Research (NCBJ) and leads the Novel Radiopharmaceuticals Group at the NOMATEN Centre of Excellence within the NCBJ. Throughout his career, he has been the Principal Investigator on several projects funded by prestigious Polish agencies, including the National Science Centre, the National Centre for Research and Development, and the Polish National Agency for Academic Exchange. Additionally, he has been awarded scholarships from the Polish-US Fulbright Commission (2006) and the International Atomic Energy Agency (2007).

 

Dr Pruszyński’s research focuses on the design and synthesis of molecular radiopharmaceuticals and their preclinical evaluation for diagnostic and therapeutic applications. His work significantly contributes to understanding how radiolabelling procedures, involving chelators or prosthetic groups, impact the biological activity of targeting vectors.

Scopus Author ID: DYN-7209-2022
Web of Science ResearcherID: GBF-6750-2022
ORCID: 0000-0001-8835-2462

 

Image
Marek Pruszyński, PhD, DSc


This project has received funding from the European Union Horizon 2020 research and innovation
programme under grant agreement No 857470 and from European Regional Development Fund
via Foundation for Polish Science International Research Agenda PLUS programme grant
No MAB PLUS/2018/8.
Poland
The project is co-financed from the state budget within the framework of the undertaking of the Minister of Science and Higher Education "Support for the activities of Centers of Excellence established under Horizon 2020".

Grant: 5 143 237,70 EUR
Total value: 29 971 365,00 EUR
Date of signing the funding agreement: December 2023

The purpose of the undertaking is to support entities of the higher education and science system that have received funding from the European Union budget in the competition H2020-WIDESPREAD-2018-2020/WIDESPREAD-01-2018-2019: Teaming Phase 2. in the preparation, implementation and updating of activities, maintenance of material resources necessary for carrying out activities, acquisition and modernization of scientific and research apparatus, maintenance and development of personnel potential necessary for the implementation of activities, and dissemination of the results of scientific activities.